| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |